New antibacterial-core structures based on styryl quinolinium

Heteroaryl-Ethylenes as New Lead Compounds in the Fight against High Priority Bacterial Strains

The widespread use of antibiotics has led to a gradual increase in drug-resistant bacterial infections, which severely weakens the clinical efficacy of antibacterial therapies. In recent decades, stilbenes aroused great interest because of their high bioavailability, as well as their manifold biological activity. Our research efforts are focused on synthetic heteroaromatic stilbene derivatives as they represent a potentially new type of antibiotic with a wide antibacterial spectrum. Herein, a preliminary molecular modeling study and a versatile synthetic scheme allowed us to define eight heteroaromatic stilbene derivatives with potential antimicrobial activity. In order to evaluate our compound’s activity spectrum and antibacterial ability, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests have been performed on Gram-positive and Gram-negative ATCC strains. Compounds PB4, PB5, PB7, and PB8 showed the best values in terms of MIC and were also evaluated for MBC, which was found to be greater than MIC, confirming a bacteriostatic activity. For all compounds, we evaluated toxicity on colon-rectal adenocarcinoma cells tumor cells (CaCo2), once it was established that the whole selected set was more active than 5-Fluorouracil in reducing CaCo-2 cells viability. To the best of our knowledge, the biological assays have shown for these derivatives an excellent bacteriostatic activity, compared to similar molecular structures previously reported, thus paving the way for a new class of antibiotic compounds.

Anti-biofouling microfiltration membranes based on 1-vinyl-3-butylimidazolium chloride grafted PVDF with improved bactericidal properties and vitro biocompatibility

Polyvinylidene fluoride (PVDF) porous membranes have been widely used as the filtration and separation industry. Herein, novel microfiltration membranes based on 1-vinyl-3-butylimidazolium chloride ([VBIm][Cl]) grafted PVDF (PVDF-g-[VBIm][Cl]) were prepared via the non-solvent induced phase separation method. The chemical composition and microstructure of PVDF-g-[VBIm][Cl] membranes were characterized by Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy, Scanning electron microscopy and Water contact angle measurements. The results showed that an increasing in [VBIm][Cl] grafting content leads to the increasing hydrophilicity and wetting capacity of the PVDF-g-[VBIm][Cl] porous membranes. The anti-biofouling properties of membranes were evaluated by measuring the water flux before and after Bovine serum albumin solution treatment. It was found that the modified membranes presented a good anti-biofouling property. The degree of irreversible flux loss caused by protein adsorption dramatically reduced from 42.1% to 2.9% compared with the pristine hydrophobic PVDF membranes. Meanwhile, these PVDF-g-[VBIm][Cl] membranes also exhibited excellent bactericidal properties against both gram-positive bacteria Staphylococcus saureus and gram-negative bacteria Escherichia coli, while PVDF membranes did not show any antibacterial activity. The vitro biocompatibility of the modified membranes was studied by hemolysis analysis, the platelet adhesion observation, thromboelastography assay and cytotoxicity assay. It was found that the incorporation of [VBIm][Cl] into PVDF membranes has less effect on the hemolysis and cytotoxicity of PVDF membranes. Furthermore, both hydrophilicity and charges of the membrane surface played important role in the adhesion and activation of platelet cells, which consequently affected the clotting process of whole blood. The membrane with appropriate [VBIm][Cl] grafting ratio (2.94 wt.%) exhibited good hemocompatibility with less blood coagulation effect. As an ultrafiltration membrane, PVDF-g-[VBIm][Cl] membranes have potential applications in the biomedical field due to the improved antibacterial property and biocompatibility.

Antibacterial activity of 3-methylbenzo[d]thiazol-methylquinolinium derivatives and study of their action mechanism

The increasing incidence of multidrug resistant bacterial infection renders an urgent need for the development of new antibiotics. To develop small molecules disturbing FtsZ activity has been recognized as promising approach to search for antibacterial of high potency systematically. Herein, a series of novel quinolinium derivatives were synthesized and their antibacterial activities were investigated. The compounds show strong antibacterial activities against different bacteria strains including MRSA, VRE and NDM-1 Escherichia coli. Among these derivatives, a compound bearing a 4-fluorophenyl group (A2) exhibited a superior antibacterial activity and its MICs to the drug-resistant strains are found lower than those of methicillin and vancomycin. The biological results suggest that these quinolinium derivatives can disrupt the GTPase activity and dynamic assembly of FtsZ, and thus inhibit bacterial cell division and then cause bacterial cell death. These compounds deserve further evaluation for the development of new antibacterial agents targeting FtsZ.